Aviv Regev

Aviv Regev
Aviv Regev
	Regev at the Intelligent Systems for Molecular Biology conference in 2017
Born	July 11, 1971
Alma mater	Tel Aviv University (M.Sc., Ph.D.)
Awards	Overton Prize (2008); ISCB Innovator Award (2017); Paul Marks Prize for Cancer Research (2017); Member of the National Academy of Sciences (2019); Keio Medical Science Prize (2020);
	Scientific career
Fields	Bioinformatics; Computational Biology
Institutions	Massachusetts Institute of Technology; Howard Hughes Medical Institute; Broad Institute; Genentech;
Doctoral advisor	Eva Jablonka; Ehud Shapiro
Website	www.broadinstitute.org/bios/aviv-regev

Aviv Regev (born 11 July 1971) is a computational biologist and systems biologist and Executive Vice President and Head of Genentech Research and Early Development in Genentech/Roche. She is a core member (on leave) at the Broad Institute of MIT and Harvard and professor (on leave) at the Department of Biology of the Massachusetts Institute of Technology. Regev is a pioneer of single cell genomics and of computational and systems biology of gene regulatory circuits. She founded and leads the Human Cell Atlas project, together with Sarah Teichmann.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.